Elicio Therapeutics, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

NanoString Technologies, Inc.

Enzo Biochem, Inc.

Avrobio, Inc.

Eliem Therapeutics, Inc.

Elicio Therapeutics, Inc.

Athira Pharma, Inc.

BioXcel Therapeutics, Inc.

Turnstone Biologics Corp.

YS Biopharma Co. Ltd.

Vaccinex, Inc.

Affimed NV

Why is Elicio Therapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Elicio Therapeutics, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Elicio Therapeutics, Inc.

24.69%

0.44

80.53%

S&P 500

16.12%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

4.37%

EBIT to Interest (avg)

-27.45

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-2.03

Sales to Capital Employed (avg)

0.04

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

14.80%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

58.67

EV to EBIT

-5.05

EV to EBITDA

-5.19

EV to Capital Employed

-35.11

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-1102.54%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

OPERATING PROFIT(Q)

Highest at USD -7.76 MM

PRE-TAX PROFIT(Q)

Highest at USD -8.27 MM

NET PROFIT(Q)

Highest at USD -8.27 MM

EPS(Q)

Highest at USD -0.6

-11What is not working for the Company

INTEREST(HY)

At USD 0.62 MM has Grown at 233.33%

OPERATING CASH FLOW(Y)

Lowest at USD -38.9 MM

Here's what is working for Elicio Therapeutics, Inc.

Operating Profit

Highest at USD -7.76 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit

Highest at USD -8.27 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

Highest at USD -8.27 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

EPS

Highest at USD -0.6

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Elicio Therapeutics, Inc.

Interest

At USD 0.62 MM has Grown at 233.33%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Cash Flow

Lowest at USD -38.9 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)